New diabetes clinical trial: A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Published on: October 09, 2025 at 11:00PM
Conditions: Obesity; Overweight; Diabetes Mellitus, Type 2
Interventions: Drug: Macupatide; Drug: Eloralintide; Drug: Macupatide Placebo; Drug: Eloralintide Placebo
Sponsors: Eli Lilly and Company
Not yet recruiting
https://ift.tt/c6btWE3